Ascentage Pharma Group International (AAPG) Receivables - Other (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Receivables - Other for 3 consecutive years, with $205144.2 the latest figure, recorded in Q4 2025.

• Quarterly Receivables - Other fell 75.99% year-over-year to $205144.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $205144.2 (down 75.99% YoY) and the FY2025 annual result came in at $208000.0, down 75.27% from the prior year.
• Receivables - Other eased to $205144.2 in Q4 2025 per AAPG's latest filing, from $854366.9 in the prior quarter.
• Over the last five years, Receivables - Other for AAPG reached as high as $921795.6 in Q4 2023 and fell as low as $205144.2 in Q4 2025.
• A 3-year average of $660435.6 and a median of $854366.9 in 2024 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2024 — Receivables - Other dropped 7.31% — and 2025, when it plunged 75.99%.
• Year by year, Receivables - Other stood at $921795.6 in 2023, then retreated by 7.31% to $854366.9 in 2024, then plunged by 75.99% to $205144.2 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $205144.2, $854366.9, and $921795.6 for Q4 2025, Q4 2024, and Q4 2023 respectively.